Genesis HealthCare (GEN) Tops Q1 EPS by 2c; offers guidance

Genesis HealthCare (NASDAQ: GEN) reported Q1 EPS of $0.71, $0.02 better than the analyst estimate of $0.69. Revenue for the quarter came in at $1.34 billion versus the consensus estimate of $1.27 billion.

GUIDANCE:

Genesis HealthCare sees Q2 2027 EPS of $0.71-$0.73, versus the consensus of $0.71. Genesis HealthCare sees Q2 2027 revenue of $1.325-1.35 billion, versus the consensus of $1.325 billion.

Genesis HealthCare sees FY2027 EPS of $2.87-$2.97, versus the consensus of $2.90. Genesis HealthCare sees FY2027 revenue of $5.375-5.475 billion, versus the consensus of $5.376 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Robinhood Ventures Fund II opens at $22.50, IPO at $25
• Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
• Axos Financial (AX) PT Raised to $120 at Benchmark